Pacira BioSciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $1.18B | $1.89B | $226.8M |
| Jun 2022 | $977.4M | $1.73B | $122.1M |
| Sep 2022 | $964.2M | $1.73B | $109.4M |
| Dec 2022 | $906.2M | $1.68B | $104.1M |
| Mar 2023 | $755.4M | $1.52B | $35.5M |
| Jun 2023 | $734.4M | $1.54B | $86.8M |
| Sep 2023 | $702.9M | $1.53B | $99.1M |
| Dec 2023 | $704.3M | $1.57B | $153.3M |
| Mar 2024 | $691.2M | $1.58B | $184.1M |
| Jun 2024 | $767.5M | $1.65B | $247.1M |
| Sep 2024 | $772.1M | $1.52B | $246.0M |
| Dec 2024 | $775.2M | $1.55B | $276.8M |
| Mar 2025 | $788.1M | $1.59B | $283.6M |
| Jun 2025 | $779.5M | $1.54B | $300.5M |
| Sep 2025 | $570.4M | $1.30B | $147.6M |
| Dec 2025 | $571.8M | $1.26B | $158.5M |
| Mar 2026 | $554.6M | $1.21B | $144.3M |
| Jun 2026 | $572.0M | $1.24B | $205.9M |